Accessibility Statement Skip Navigation
  • Back to Global Sites
  • +971 (0) 4 368 1644
  • GDPR
  • Journalists
  • Send a Release
PR Newswire: news distribution, targeting and monitoring
  • News
  • Products
  • Contact
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • Telephone

    • +971 (0) 4 368 1644 from 8 AM - 5:30 PM GMT

    • Contact
    • Contact

      +971 (0) 4 368 1644
      from 8 AM - 5:30 PM GMT

  • Request More Information
  • Journalists
  • GDPR
  • Request More Information
  • Journalists
  • GDPR
  • Request More Information
  • Journalists
  • GDPR
  • Request More Information
  • Journalists
  • GDPR

TVM Capital Healthcare Appoints Former Vice Minister of Health in the Kingdom of Saudi Arabia, H.E. Hamad M. AlDhewalia, as Operating Partner
  • USA - English
  • Middle East - Arabic

TVM Capital Healthcare Logo

News provided by

TVM Capital Healthcare

18 Aug, 2025, 06:00 GMT

Share this article

Share toX

Share this article

Share toX

 New Appointment Underscores Firm's Decade-Long Legacy of Addressing Saudi Arabia's Healthcare Gaps through Innovative Business Models

RIYADH, Saudi Arabia and DUBAI, UAE, Aug. 18, 2025 /PRNewswire/ -- TVM Capital Healthcare ("TVM"), a healthcare-focused private equity firm specialized in emerging markets and high-impact investments across the Middle East and Southeast Asia, is proud to announce H.E. Hamad M. AlDhewalia's appointment as Operating Partner. Having served as a Senior Partner with the firm for the past three years, this new role represents a more significant leadership position. With a distinguished career that includes serving as Saudi Arabia's Vice Minister of Health Affairs and General Manager of Medical Services at Saudi Aramco, he brings invaluable insight, connectivity, and leadership to further strengthen the firm as an investor and operator in the Kingdom.

H.E. Hamad M. AlDhewalia's appointment comes at a pivotal moment in the firm's journey, as TVM Capital Healthcare continues to expand its investment and company building activity across Saudi Arabia, supporting Vision 2030's transformative healthcare agenda. His unmatched understanding of the Kingdom's health system and policy landscape — combined with a legacy of leadership in both public and private healthcare — will be instrumental in advancing the firm's investments and operations in specialty care, digital health, and local pharmaceutical manufacturing.

Over a career spanning more than four decades, H.E. AlDhewalia has held key leadership roles including Vice Minister of Health for Health Affairs (2015–2019), Advisor to the Minister of Health, and CEO of major hospital networks such as King Abdullah Medical Complex and Al-Ahsa Hospital. Earlier in his career, he served as General Manager of Medical Services at Saudi Aramco, where he championed innovation and excellence in employee healthcare.

"I am honored to join TVM Capital Healthcare at a time when its level of investment and impact in the Kingdom is expanding rapidly," said H.E. Hamad M. AlDhewalia. "The firm's long-term commitment to the region — not just as an investor, but as a true builder of healthcare solutions — strongly aligns with my own passion for improving the quality of patient care, expanding access, and driving innovation. I look forward to contributing to its next phase of growth."

TVM Capital Healthcare is a pioneer in private equity healthcare investment in Saudi Arabia, with a track record of identifying unmet medical needs and building innovative companies with global relevance. The firm is the only international healthcare investor to have consistently operated in the Kingdom over the past ten years, conceptualizing business models, funding quality care delivery, and delivering strong returns alongside measurable impact.

Dr. Helmut Schuehsler, Chairman and CEO of TVM Capital Healthcare, commented, "As the Kingdom accelerates its healthcare transformation under Vision 2030, the addition of H.E. AlDhewalia marks a significant step forward for the firm in delivering its mission: to create meaningful impact, deliver strong returns, and contribute to system-wide improvement in healthcare access, quality, and resilience. We are deeply honored to announce him as an Operating Partner. His lifelong commitment to public service, healthcare advancement, and community well-being in Saudi Arabia is a perfect match for our mission."

TVM Capital Healthcare's latest Afiyah Fund — the only dedicated healthcare fund in Saudi Arabia — closed at $254 million in 2024 and has already backed high-potential platforms such as Baraya Extended Care, which is addressing the significant continuum of care gap in the Kingdom; neurocare, a global innovator in mental health treatment; and Boston Oncology Arabia, which is reshaping local pharmaceutical manufacturing with high-quality, affordable medicines.

Other examples of TVM Capital Healthcare's track record of transforming healthcare systems in the Saudi market include the founding of Cambridge Medical and Rehabilitation Center (CMRC) — now the leading post-acute care provider in the region — and the expansion of ProVita International Medical Center, bringing long-term care for ventilated patients to Saudi Arabia for the first time. Through partnerships with global institutions such as US-based Spaulding Rehabilitation Network (Harvard-affiliated) and Netherlands-based Spectator Healthcare Technology, TVM has facilitated the transfer of knowledge, training, and innovation to the Kingdom, while creating local jobs and strengthening the healthcare workforce.

With offices in Riyadh, Dubai, and Singapore, TVM Capital Healthcare manages and advises nearly $500 million in committed capital and maintains a deep bench of Operating Partners and Senior Advisors globally. Its strategy blends growth capital with operational support to deliver scalable, sustainable healthcare platforms in underserved markets.

Media Contact:
Holly Radel
[email protected]
TVM Capital Healthcare
www.tvmcapitalhealthcare.com 

Logo - https://mma.prnewswire.com/media/1446186/4906310/TVM_Capital_Healthcare_Logo.jpg

Modal title

Also from this source

TVM Capital Healthcare Announces First Closing of its USD 150 Million Southeast Asia Fund

TVM Capital Healthcare Announces First Closing of its USD 150 Million Southeast Asia Fund

TVM Capital Healthcare, a global private equity investor and operator specialized in healthcare growth capital across emerging markets, today...

Baraya Extended Care Closes Series B Funding Round Bringing Total Capital Raised to USD 124 Million from TVM Capital Healthcare and a Syndicate of Prominent Investors

Baraya Extended Care Closes Series B Funding Round Bringing Total Capital Raised to USD 124 Million from TVM Capital Healthcare and a Syndicate of Prominent Investors

TVM Capital Healthcare announces the closing of a Series B fundraising, surpassing its target and bringing the total capital raised to USD 124...

المزيد من الإصدارات من هذا المصدر

Explore

Health Care & Hospitals

Health Care & Hospitals

Medical Pharmaceuticals

Medical Pharmaceuticals

Medical Equipment

Medical Equipment

Personnel Announcements

Personnel Announcements

المزيد من البيانات الصحفية في مواضيع ذات صلة

Contact PR Newswire

  • +971 (0) 4 368 1644
    from 8 AM - 5:30 PM GMT

Global Sites

  • APAC
  • APAC - Traditional Chinese
  • Asia
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany

 

  • India
  • Indonesia
  • Israel
  • Italy
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland

 

  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • United States

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921
Global Sites
  • Asia
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Israel
  • Italy
  • Mexico
  • Middle East
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • United States
+971 (0) 4 368 1644
from 8 AM - 5:30 PM GMT
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • Cookie Settings
Copyright © 2025 Cision US Inc.